|
Q3 FY2025
As of Jun 30, 2026
|
Q2 FY2025
As of Mar 31, 2026
|
Q1 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Sep 30, 2025
|
Q3 FY2024
As of Jun 30, 2025
|
Q2 FY2024
As of Mar 31, 2025
|
Q1 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Sep 30, 2024
|
Q3 FY2023
As of Jun 30, 2024
|
Q2 FY2023
As of Mar 31, 2024
|
Q1 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Sep 30, 2023
|
Q3 FY2022
As of Jun 30, 2023
|
Q2 FY2022
As of Mar 31, 2023
|
Q1 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Sep 30, 2022
|
Q3 FY2021
As of Jun 30, 2022
|
Q2 FY2021
As of Mar 31, 2022
|
Q1 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Investment in BellRing | ||||||||||||||||||||
| Investments held in trust | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets held for sale | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other liabilities held for sale | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 50.0 shares authorized; zero shares outstanding in each year | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Total Shareholders’ Equity Excluding Noncontrolling Interest | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
